ATE326979T1 - Asthma- und allergiebehandlung die auf t- lymphozyten und/oder eosinophile ausgerichtet ist - Google Patents

Asthma- und allergiebehandlung die auf t- lymphozyten und/oder eosinophile ausgerichtet ist

Info

Publication number
ATE326979T1
ATE326979T1 AT00909548T AT00909548T ATE326979T1 AT E326979 T1 ATE326979 T1 AT E326979T1 AT 00909548 T AT00909548 T AT 00909548T AT 00909548 T AT00909548 T AT 00909548T AT E326979 T1 ATE326979 T1 AT E326979T1
Authority
AT
Austria
Prior art keywords
treatment
lymphocytes
day
eosinophils
diseases
Prior art date
Application number
AT00909548T
Other languages
English (en)
Inventor
Nedaa Abdul-Ghani Nasif
Original Assignee
Al Jassim Rawaa
Al Kaisi Ban
James David
Nedaa Abdul Ghani Nasif
Ahmad Nagham Zuhair
Fadhel Ali Zuhair A
Ahmad Zeena Z
Ahmad Noor Z
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9904777.1A external-priority patent/GB9904777D0/en
Priority claimed from GBGB9913341.5A external-priority patent/GB9913341D0/en
Application filed by Al Jassim Rawaa, Al Kaisi Ban, James David, Nedaa Abdul Ghani Nasif, Ahmad Nagham Zuhair, Fadhel Ali Zuhair A, Ahmad Zeena Z, Ahmad Noor Z filed Critical Al Jassim Rawaa
Application granted granted Critical
Publication of ATE326979T1 publication Critical patent/ATE326979T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT00909548T 1999-03-02 2000-03-02 Asthma- und allergiebehandlung die auf t- lymphozyten und/oder eosinophile ausgerichtet ist ATE326979T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904777.1A GB9904777D0 (en) 1999-03-02 1999-03-02 Novel method, an asthma therapy that act on eosinophils and/or t-lymphocytes
GBGB9913341.5A GB9913341D0 (en) 1999-03-02 1999-06-08 Treatment and prevention of type 1 IgE-mediated hypersensitivity

Publications (1)

Publication Number Publication Date
ATE326979T1 true ATE326979T1 (de) 2006-06-15

Family

ID=26315206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00909548T ATE326979T1 (de) 1999-03-02 2000-03-02 Asthma- und allergiebehandlung die auf t- lymphozyten und/oder eosinophile ausgerichtet ist

Country Status (7)

Country Link
EP (1) EP1242102B1 (de)
AT (1) ATE326979T1 (de)
AU (1) AU3182900A (de)
DE (1) DE60028243T2 (de)
ES (1) ES2267505T3 (de)
GB (1) GB2348132B (de)
WO (1) WO2000051580A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4180258B2 (ja) * 2001-08-06 2008-11-12 西川ゴム工業株式会社 ＩｇＥ抗体抑制剤および食品
EP2263664A1 (de) * 2009-05-18 2010-12-22 Nestec S.A. Opioid-Rezeptoren stimulierender Wirkstoff (Thymoquinon, Nigella sativa) und Lebensmittelallergie
PL412214A1 (pl) * 2015-05-04 2016-11-07 Biovico Spółka Z Ograniczoną Odpowiedzialnością Kompozycja roślinna o właściwościach przeciwzapalnych, przeciwalergicznych i/lub przeciwastmatycznych oraz jej zastosowanie
CN115364196B (zh) * 2022-09-29 2025-04-15 宁夏医科大学 枸杞糖肽在制备治疗变应性气道炎性疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482711A (en) * 1993-08-25 1996-01-09 Medenica; Rajko D. Use of Nigella sativa to increase immune function
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US5648089A (en) * 1995-07-03 1997-07-15 Shawkat; Tarek Extract solution and herbal mixture for treatment of hepatitis
EP1003850B1 (de) * 1997-06-06 2009-05-27 The Regents of the University of California Inhibitoren von immunstimulatorischen dna sequenz aktivität

Also Published As

Publication number Publication date
WO2000051580A3 (en) 2001-10-18
DE60028243T2 (de) 2007-03-29
EP1242102A2 (de) 2002-09-25
AU3182900A (en) 2000-09-21
ES2267505T3 (es) 2007-03-16
GB0005003D0 (en) 2000-04-19
DE60028243D1 (de) 2006-06-29
GB2348132B (en) 2004-08-04
WO2000051580A2 (en) 2000-09-08
EP1242102B1 (de) 2006-05-24
GB2348132A (en) 2000-09-27

Similar Documents

Publication Publication Date Title
CN112915155B (zh) 一种用于外感热病恢复期的中药组合物及其制备方法和应用
RU2348438C1 (ru) Способ лечения хронической обструктивной болезни легких в форме пылевых бронхитов у работников угольной промышленности
Liu et al. Scorpio and Scolopendra attenuate inflammation and articular damage in rats with collagen-induced arthritis
ATE326979T1 (de) Asthma- und allergiebehandlung die auf t- lymphozyten und/oder eosinophile ausgerichtet ist
JP2000512270A (ja) 単純ヘルペスの処置のための組成物および方法
RU2163130C1 (ru) Способ лечения хронического тонзиллита
CN1235608C (zh) 治疗前列腺炎、前列腺增生、泌尿系统感染的药物及制法
CN106344612A (zh) 一种用于治疗自身免疫性皮肤病的外用药物及其制备方法和应用
HK1049964A1 (zh) 针对t-淋巴细胞和/或嗜酸性粒细胞的治疗哮喘/变态反应的方法
CN106344613A (zh) 一种nk细胞原液在制备治疗皮肤病药物中的应用
Wu et al. Efficacy and safety of Pien Tze Huang capsules in patients with herpes zoster: A multicenter, randomized, double-blinded, and placebo-controlled trial
CN101703701A (zh) 一种治疗面神经麻痹的药物
CN101129425B (zh) 一种治疗带状疱疹的中药
CN1660256A (zh) 一种治疗上呼吸道炎所致咳嗽的药物
Sutema et al. Analysis of Factors Affecting Healing of Acute Pharyngitis Viral Patients in Puskesmas I, Klungkung-Bali
CN1742912A (zh) 治疗和预防慢性阻塞性肺病的药
CN1165331C (zh) 治疗结核病的中药制剂
CN105055926A (zh) 一种治疗小儿手足口病的药物组合物
Liu et al. Dongbai Tonglin Mixture for the treatment of chronic prostatitis
CN110420220A (zh) 含土壤物质在制备预防和/或治疗内分泌紊乱疾病药物或保健品中的应用
CN102988493B (zh) 一种治疗哮喘的中药复方制剂及其制备方法
CN103736075B (zh) 锌硒宝片及保妇康栓联合锌硒宝片在制备治疗老年性阴道炎药物中的应用
CN104784332B (zh) 一种治疗慢性尿路感染的药剂的制备方法
Lamothe et al. Dupilumab Superior to Other Asthma Biologics to Treat Allergic Bronchopulmonary Aspergillosis in a Retrospective Study
CN1153646A (zh) 小儿消炎止咳灵及制取工艺

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties